Adaptive Cellular Immunity against African Swine Fever Virus Infections
African swine fever virus (ASFV) remains a threat to global pig populations. Infections with ASFV lead to a hemorrhagic disease with up to 100% lethality in Eurasian domestic and wild pigs. Although myeloid cells are the main target cells for ASFV, T cell responses are impacted by the infection as well. The complex responses remain not well understood, and, consequently, there is no commercially available vaccine. Here, we review the current knowledge about the induction of antiviral T cell responses by cells of the myeloid lineage, as well as T cell responses in infected animals, recent efforts in vaccine research, and T cell epitopes present in ASFV.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Pathogens (Basel, Switzerland) - 11(2022), 2 vom: 20. Feb. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Schäfer, Alexander [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adaptive immunity |
---|
Anmerkungen: |
Date Revised 10.03.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/pathogens11020274 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM337467242 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM337467242 | ||
003 | DE-627 | ||
005 | 20231225234454.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/pathogens11020274 |2 doi | |
028 | 5 | 2 | |a pubmed24n1124.xml |
035 | |a (DE-627)NLM337467242 | ||
035 | |a (NLM)35215216 | ||
035 | |a (PII)274 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Schäfer, Alexander |e verfasserin |4 aut | |
245 | 1 | 0 | |a Adaptive Cellular Immunity against African Swine Fever Virus Infections |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 10.03.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a African swine fever virus (ASFV) remains a threat to global pig populations. Infections with ASFV lead to a hemorrhagic disease with up to 100% lethality in Eurasian domestic and wild pigs. Although myeloid cells are the main target cells for ASFV, T cell responses are impacted by the infection as well. The complex responses remain not well understood, and, consequently, there is no commercially available vaccine. Here, we review the current knowledge about the induction of antiviral T cell responses by cells of the myeloid lineage, as well as T cell responses in infected animals, recent efforts in vaccine research, and T cell epitopes present in ASFV | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a African swine fever virus | |
650 | 4 | |a T cells | |
650 | 4 | |a adaptive immunity | |
650 | 4 | |a antigen-presenting cells | |
650 | 4 | |a cytokines | |
650 | 4 | |a porcine disease | |
650 | 4 | |a vaccines | |
700 | 1 | |a Franzoni, Giulia |e verfasserin |4 aut | |
700 | 1 | |a Netherton, Christopher L |e verfasserin |4 aut | |
700 | 1 | |a Hartmann, Luise |e verfasserin |4 aut | |
700 | 1 | |a Blome, Sandra |e verfasserin |4 aut | |
700 | 1 | |a Blohm, Ulrike |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Pathogens (Basel, Switzerland) |d 2011 |g 11(2022), 2 vom: 20. Feb. |w (DE-627)NLM22512761X |x 2076-0817 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2022 |g number:2 |g day:20 |g month:02 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/pathogens11020274 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2022 |e 2 |b 20 |c 02 |